Navigation Links
New screening test for MRSA could reduce infections and costs

A team of researchers led by Dr Stephen Harbarth have claimed that a new screening test for MRSA could prove to be useful in reducing the // infection rates in hospitals and cut down the £1 billion-a-year cost incurred by the NHS in dealing with the bug.

The new test tracks the presence of the "superbug's" DNA in patient swabs. The researchers said that this test was able to reduce the time needed to identify the methicillin-resistant Staphylococcus aureus (MRSA) bug and thus avert infections. In the current study conducted at Geneva University Hospital, researchers found that if the test had not been used 55 carriers would have been missed. "A molecular MRSA detection assay (test) permits rapid identification of MRSA carriage in critically ill patients. It could help to improve MRSA control strategies, especially if it is linked to systematic on-admission screening and pre-emptive isolation of newly admitted patients," the researchers wrote in the journal Critical Care. 1,053 patients were tested in the medical and surgical ICUs at Geneva University Hospital between January 2003 and August 2005. "Despite the fact that culture-based MRSA screening techniques have proven cheap and sensitive if samples are collected from several body sites, the time to report the results remains a major issue. Definitive identification and testing results are usually available only 48 to 96 hours after sample collection, a time delay that could allow MRSA cross-transmission if patients are not presumptively placed under contact precautions," the researchers concluded.
'"/>




Page: 1

Related medicine news :

1. Need for Colon cancer screening
2. DNA biochip for genetic screening
3. Breast screening among diabetic women
4. Fast screening for macular degeneration
5. New virtual colonoscopy procedure for easier colon screening
6. Hearing loss can be detected by simple screening
7. MRI screenings may be better to identify breast cancer
8. Oral cancer screenings to reduce the mortality rates
9. Appendectomy need reduced with CT screening
10. Need for early screening and effective cancer treatment in India
11. Annual PSA screening reduces risk of prostate cancer deaths
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... , ... Cheerag D. Upadhyaya , M.D., M.Sc., FAANS has been appointed ... part of Saint Luke’s Health System . Dr. Upadhyaya has served in the ... FAANS joins Stanley P. Fisher, M.D., who has served as medical co-director ...
(Date:7/24/2017)... ... July 24, 2017 , ... A four alarm fire ... site and threatened numerous homes and businesses nearby, causing some 700 individuals to ... Los Angeles Area consulting firm Fire Protection Group, Inc. notes that the report ...
(Date:7/24/2017)... ... 24, 2017 , ... The Topricin Companies, formerly Topical Biomedics, ... revolutionary, natural, after-burn skin care product, Topricin After Burn Cream. , ... skin conditions, including cancer. In the short term, overexposure to sun, wind ...
(Date:7/24/2017)... ... 24, 2017 , ... The 2017 NCSL International Workshop & ... focuses on the new ISO/IEC 17025 standards. This marks the first time in ... calibration will be changed. , As an exhibitor, METTLER TOLEDO will showcase ...
(Date:7/24/2017)... ... 24, 2017 , ... The Magic Wand® Rechargeable, the top-of-the-line ... favorite sex toy. Created in collaboration with website Kinkly.com, the award was the ... The Magic Wand Rechargeable won in stiff competition from brands such as Lelo, ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... LAS VEGAS , July 13, 2017 It ... the United States is in the midst of ... Disease Control , since 1999, the number of overdose deaths ... , "resulting in over half a million dead from 2001 ... like codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a ...
(Date:7/12/2017)... 12, 2017  Eli Lilly and Company (NYSE: ... companies to resolve pending patent litigation in the U.S. District ... regarding the Cialis ® (tadalafil) unit dose patent. ... 2020. As part of the agreement, Cialis exclusivity is now ... "The unit dose patent for Cialis is valid ...
(Date:7/11/2017)... , July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, ... program to patients who suffer from painful intercourse and other painful pelvic ... vaginal atrophy due to menopause. ... VuVatech LLC ... created by Sarasota, Florida -based start-up company, VuVatech LLC, ...
Breaking Medicine Technology: